Trademark: 77942356
Word
YUROXAN
Status
Dead
Status Code
710
Status Date
Friday, May 25, 2018
Serial Number
77942356
Registration Number
4040189
Registration Date
Tuesday, October 18, 2011
Mark Type
4000
Filing Date
Tuesday, February 23, 2010
Published for Opposition
Tuesday, August 2, 2011
Cancellation Date
Friday, May 25, 2018

Trademark Owner History
MediGene AG - Original Registrant

Classifications
5 Pharmaceutical and veterinary preparations for humans and animals, namely, medicines, vaccines, and serums for diagnostics, testing, prevention, treatment, and therapeutics, in particular medicines for treating cardiovascular illnesses, in particular hyperlipidaemia, coronary heart diseases and cardiac insufficiency; medicines for the treatment of immunological diseases, in particular autoimmune diseases in particular rheumatic disorders, polychondritis, Bechterew's disease, fibromyalgia and lupus erythematodes, rheumatoid arthritis, polyarthritis, Crohn's disease, and multiple sclerosis; medicines for treating skin diseases, in particular acne, actinic keratosis, alopecia, atopic dermatitis, Bowen's disease, cutaneous atopy, cutaneous T-cell lymphoma, Darrier's disease, Dartroud diathesis, dermatitis, eczema, genital herpes, genital warts, herpes, hyperkeratosis, hyperpigmentation, hyperplasia of the epidermis, hypopigmentation, ichthyosis, increased proliferation of skin cells, keloids, lentigo, lichen planus, melasma, molluscum contagiosum, mycosis fungoides, neoplasias, neurodermitis, pigmentation disorders, porokeratosis of Mibelli, psoriasis, removal of tattoos, rosacea, seborrhea, seborrheic keratosis, shingles, skin diseases related to inflammatory processes of skin cells, skin ulcers, vitiligo, warts, xerosis; medicines for treating tumourous diseases, in particular Astrocytomas, basal cell carcinomas, biliary cancers, bladder cancers, bone cancers, brain cancers, breast cancers, carcinomas, cervical cancers, cervical intraepithelial neoplasias, colorectal cancers, endocrine system cancers, ependymomas, epidermoid carcinomas, fibrosarcomas, gastric cancers, gastrointestinal cancers, glioblastomas, gynecologic cancers, head and neck cancers, hemangiomas, hepatomas, Hodgkin's lymphomas, Leukemia, liver cancers, lung cancers, lymphomas, medulloblastomas, meningiomas, mesothelaiomas, metastases, myelomas, neoplasias, neurectodermal cancers, neuroblastomas, neurofibromas, neurofibrosarcomas, neuronal cancers, non-Hodgkin's lymphomas, oligodendrogliomas, ovarian carcinoma, pancreatic cancers, pediatric cancers, penile cancer, pituitary adenomas, pleural cancers, renal cancer, sarcomas, Schwannomas, skin cancers, sqamous cell carcinomas, testicular cancers, thyroid cancers, thyroid tumors, urinary tract cancers, carcinoma of the prostate, melanoma, Kaposi's sarcoma, hepatocellular carcinoma; ALL OF THE ABOVE CONSISTING OF low-molecular active substances, liposomes, aptamers, nucleic acids, peptides, proteins, protein conjugates, antibodies, T-cell proteins, enzymes and enzyme preparations, hormones, hormone analogues, attenuated viruses, virus-type particles and plant extracts
The wording "YUROXAN" has no meaning in a foreign language.

Trademark Events
May 25, 2018
Cancelled Sec. 8 (6-Yr)
Oct 18, 2016
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Oct 18, 2011
Registered-Principal Register
Aug 2, 2011
Official Gazette Publication Confirmation E-Mailed
Aug 2, 2011
Published For Opposition
Jun 28, 2011
Law Office Publication Review Completed
Jun 24, 2011
Assigned To Lie
Jun 22, 2011
Approved For Pub - Principal Register
Jun 22, 2011
Examiner's Amendment Entered
Jun 22, 2011
Notification Of Examiners Amendment E-Mailed
Jun 22, 2011
Examiners Amendment E-Mailed
Jun 22, 2011
Examiners Amendment -Written
Jan 3, 2011
Notification Of Priority Action E-Mailed
Jan 3, 2011
Priority Action E-Mailed
Jan 3, 2011
Priority Action Written
Nov 29, 2010
Teas/Email Correspondence Entered
Nov 29, 2010
Correspondence Received In Law Office
Nov 29, 2010
Teas Response To Office Action Received
May 29, 2010
Notification Of Priority Action E-Mailed
May 29, 2010
Priority Action E-Mailed
May 29, 2010
Priority Action Written
May 27, 2010
Assigned To Examiner
Mar 1, 2010
New Application Office Supplied Data Entered In Tram
Feb 26, 2010
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24